UK markets closed

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.9100+0.0400 (+0.82%)
At close: 04:00PM EDT
4.9001 -0.01 (-0.20%)
After hours: 07:43PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate-0.14-0.02-0.050.39
Low estimate-0.2-0.06-0.34-0.14
High estimate0.010.040.150.83
Year ago EPS-0.18-0.08-0.54-0.05
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate47.45M53.44M224.25M288.87M
Low estimate46M49M207M250M
High estimate51.82M56.31M232.83M339.89M
Year ago sales34.41MN/A175.51M224.25M
Sales growth (year/est)37.90%N/A27.80%28.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.22-0.18-0.17-0.16
Actual EPS-0.18-0.08-0.09-0.19
Difference0.040.10.08-0.03
Surprise %18.20%55.60%47.10%-18.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.14-0.02-0.050.39
7 days ago-0.14-0.02-0.050.39
30 days ago-0.14-0.02-0.050.39
60 days ago-0.13-0.02-0.050.4
90 days ago-0.13-0.08-0.35-0.02
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAUPHIndustrySector(s)S&P 500
Current qtr.22.20%N/AN/AN/A
Next qtr.75.00%N/AN/AN/A
Current year90.70%N/AN/AN/A
Next year880.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A